Antonio Lario
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Antonio Lario has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
- Jaime Sancho
Instituto de Parasitología y Biomedicina "López-Neyra" (IPBLN), CSIC, Armilla, Granada, Spain
6 shared publications - Mercedes Zubiaur
Department of Cell Biology and Immunology Institute of Parasitology and Biomedicine Consejo Superior de "Lo ´pez- Neyra" (IPBLN) Investigaciones Cientı ´ficas (CSIC) Granada Spain
5 shared publications - Victoria Longobardo
CSIC, IPBLN, Unidad Proteom, Granada, Spain
5 shared publications - Antonio Rosal-Vela
Biomedicine, Biotechnology and Public Health Department, Cádiz University, 11002 Cádiz, Spain
4 shared publications - Joaquin Abian
Biological and Environmental Proteomics, Institute of Biomedical Research of Barcelona (IIBB-CSIC), Roselón 161, 08036 Barcelona, Spain
3 shared publications - Marcos Iglesias
Departamento de Biología Molecular-IDIVAL Universidad de Cantabria, Santander, Spain
3 shared publications
Latest Publications
- 29 October 2016
- Published by Elsevier in Journal of Proteomics
- Vol. 152, 138-149
A multicentric study to evaluate the use of relative retention times in targeted proteomics
- 29 October 2016
- Published by Elsevier in Journal of Proteomics
- Vol. 152, 138-149
A multicentric study to evaluate the use of relative retention times in targeted proteomics
- Open Access
- 1 March 2016
- Published by Elsevier in Data in Brief
- Vol. 6, 587-602
Supporting data for the MS identification of distinct transferrin glycopeptide glycoforms and citrullinated peptides associated with inflammation or autoimmunity
- 1 March 2016
- Published by Elsevier in Data in Brief
- Vol. 6, 587-602
Open AccessSupporting data for the MS identification of distinct transferrin glycopeptide glycoforms and citrullinated peptides associated with inflammation or autoimmunity
- 14 July 2015
- Published by Wiley in Proteomics
- Vol. 15 (19) , 3382-3393
Distinct serum proteome profiles associated with collagen‐induced arthritis and complete Freund's adjuvant‐induced inflammation in CD38−/− mice: The discriminative power of protein species or proteoforms
Collagen‐type‐II‐induced arthritis (CIA) is an autoimmune disease, which involves a complex host systemic response including inflammatory and autoimmune reactions. CIA is milder in CD38−/− than in wild‐type (WT) mice. ProteoMiner‐equalized serum samples were subjected to 2D‐DiGE and MS‐MALDI‐TOF/TOF analyses to identify proteins that changed in their relative abundances in CD38−/− versus WT mice either with arthritis (CIA+), with no arthritis (CIA−), or with inflammation (complete Freund's adjuvant (CFA)‐treated mice). Multivariate analyses revealed that a multiprotein signature (n = 28) was able to discriminate CIA+ from CIA− mice, and WT from CD38−/− mice within each condition. Likewise, a distinct multiprotein signature (n = 16) was identified which differentiated CIA+ CD38−/− mice from CIA+ WT mice, and lastly, a third multiprotein signature (n = 18) indicated that CD38−/− and WT mice could be segregated in response to CFA treatment. Further analyses showed that the discriminative power to distinguish these groups was reached at protein species level and not at the protein level. Hence, the need to identify and quantify proteins at protein species level to better correlate proteome changes with disease processes. It is crucial for plasma proteomics at the low‐abundance protein species level to apply the ProteoMiner enrichment. All MS data have been deposited in the ProteomeXchange with identifiers PXD001788, PXD001799 and PXD002071 (http://proteomecentral.proteomexchange.org/dataset/PXD001788, http://proteomecentral.proteomexchange.org/dataset/PXD001799 and http://proteomecentral.proteomexchange.org/dataset/PXD002071).
- 14 July 2015
- Published by Wiley in Proteomics
- Vol. 15 (19) , 3382-3393
Distinct serum proteome profiles associated with collagen‐induced arthritis and complete Freund's adjuvant‐induced inflammation in CD38−/− mice: The discriminative power of protein species or proteoforms
Collagen‐type‐II‐induced arthritis (CIA) is an autoimmune disease, which involves a complex host systemic response including inflammatory and autoimmune reactions. CIA is milder in CD38−/− than in wild‐type (WT) mice. ProteoMiner‐equalized serum samples were subjected to 2D‐DiGE and MS‐MALDI‐TOF/TOF analyses to identify proteins that changed in their relative abundances in CD38−/− versus WT mice either with arthritis (CIA+), with no arthritis (CIA−), or with inflammation (complete Freund's adjuvant (CFA)‐treated mice). Multivariate analyses revealed that a multiprotein signature (n = 28) was able to discriminate CIA+ from CIA− mice, and WT from CD38−/− mice within each condition. Likewise, a distinct multiprotein signature (n = 16) was identified which differentiated CIA+ CD38−/− mice from CIA+ WT mice, and lastly, a third multiprotein signature (n = 18) indicated that CD38−/− and WT mice could be segregated in response to CFA treatment. Further analyses showed that the discriminative power to distinguish these groups was reached at protein species level and not at the protein level. Hence, the need to identify and quantify proteins at protein species level to better correlate proteome changes with disease processes. It is crucial for plasma proteomics at the low‐abundance protein species level to apply the ProteoMiner enrichment. All MS data have been deposited in the ProteomeXchange with identifiers PXD001788, PXD001799 and PXD002071 (http://proteomecentral.proteomexchange.org/dataset/PXD001788, http://proteomecentral.proteomexchange.org/dataset/PXD001799 and http://proteomecentral.proteomexchange.org/dataset/PXD002071).
- 1 February 2015
- Published by SAGE Publications in European Journal of Mass Spectrometry
- Vol. 21 (1) , 19-26
Application of Matrix-Assisted Laser Desorption and Ionization Time of Flight Mass Spectrometry to the Study of the Proteinaceous Binders in Paint: Blue Paint Composition in the Series “The Life of Virgin” by Alonso Cano (17th Century) as a Case Study
The identification of proteinaceous materials in paint constituents provides very valuable information regarding the techniques used by the painter and the most suitable procedures for conserving and restoring their works. Although the analysis of proteinaceous materials is nowadays a common task when dealing with works of art, the reliable detection and identification of protein traces is still complicated, particularly when very small samples can be taken that may contain a mixture of different organic materials (oils, waxes, resins, gums etc.). We therefore proposed a proteomic approach to investigate protein materials in paintings at trace levels in order to obtain a better understanding of the painter's technique. After trypsin digestion of the paint samples, mass spectra were obtained by matrix-assisted laser desorption and ionization time of flight mass spectrometry (MALDI-TOF-MS) and they were compared with the Mascot database and with theoretical digested proteins. This study contributes to the knowledge about the technique used by Alonso Cano (Granada, Spain, 1601–1667), one of the most original and brilliant artists from the Spanish Golden Age (17th century), in the series called the Life of the Virgin (six paintings), part of the iconographic program about the life of the Virgin Mary, nowadays seen in the main chapel of Granada Cathedral. The objective of the present study was to test the use of proteinaceous material, mainly egg yolk, in the paint used by Cano, as suggested in previous research, although this would have been unusual at that time when most artists used oil paints. Based on the results of the analysis here presented, the use of protein in the binding media can most likely be excluded.
- 1 February 2015
- Published by SAGE Publications in European Journal of Mass Spectrometry
- Vol. 21 (1) , 19-26
Application of Matrix-Assisted Laser Desorption and Ionization Time of Flight Mass Spectrometry to the Study of the Proteinaceous Binders in Paint: Blue Paint Composition in the Series “The Life of Virgin” by Alonso Cano (17th Century) as a Case Study
The identification of proteinaceous materials in paint constituents provides very valuable information regarding the techniques used by the painter and the most suitable procedures for conserving and restoring their works. Although the analysis of proteinaceous materials is nowadays a common task when dealing with works of art, the reliable detection and identification of protein traces is still complicated, particularly when very small samples can be taken that may contain a mixture of different organic materials (oils, waxes, resins, gums etc.). We therefore proposed a proteomic approach to investigate protein materials in paintings at trace levels in order to obtain a better understanding of the painter's technique. After trypsin digestion of the paint samples, mass spectra were obtained by matrix-assisted laser desorption and ionization time of flight mass spectrometry (MALDI-TOF-MS) and they were compared with the Mascot database and with theoretical digested proteins. This study contributes to the knowledge about the technique used by Alonso Cano (Granada, Spain, 1601–1667), one of the most original and brilliant artists from the Spanish Golden Age (17th century), in the series called the Life of the Virgin (six paintings), part of the iconographic program about the life of the Virgin Mary, nowadays seen in the main chapel of Granada Cathedral. The objective of the present study was to test the use of proteinaceous material, mainly egg yolk, in the paint used by Cano, as suggested in previous research, although this would have been unusual at that time when most artists used oil paints. Based on the results of the analysis here presented, the use of protein in the binding media can most likely be excluded.
- 24 December 2014
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 140 (5) , 1717-1730
Cluster-based comparison of the peptide mass fingerprint obtained by MALDI-TOF mass spectrometry. A case study: long-term stability of rituximab
We evaluated the use of the peptide mass fingerprint (PMF) obtained by matrix assisted laser desorption and ionization (MALDI) time-of-flight mass spectrometry (TOF-MS) to track changes in the structure of a protein. The first problem we had to overcome was the inherent complexity of the PMF, which makes it difficult to compare. We dealt with this problem by developing a cluster-based comparison algorithm which takes into account the proportional error made by the mass spectrometer. This procedure involves grouping together similar masses in an intelligent manner, so that we can determine which data correspond to the same peptide (any slight differences can be explained as experimental errors), and which of them are too different and thus more likely to represent different peptides. The proposed algorithm was applied to track changes in a commercially available monoclonal antibody (mAb), namely rituximab (RTX), prepared under the usual hospital conditions and stored refrigerated (4 °C) and frozen (−20 °C) for a long term study. PMFs were obtained periodically over three months. For each checked time, five replicates of the PMFs were obtained in order to evaluate the similarities between them by means of the occurrences of the particular peptides (m/z). After applying the algorithm to the PMF, different approaches were used to analyse the results. Surprisingly, all of them suggested that there were no differences between the two storage conditions tested, i.e. the RTX samples were almost equally well preserved when stored refrigerated at 4 °C or frozen at −20 °C. The cluster-based methodology is new in protein mass spectrometry and could be useful as an easy test for major changes in proteins and biopharmaceutics for diverse applications in industry and other fields, and could provide additional stability data in relation to the practical use of anticancer drugs.
- 24 December 2014
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 140 (5) , 1717-1730
Cluster-based comparison of the peptide mass fingerprint obtained by MALDI-TOF mass spectrometry. A case study: long-term stability of rituximab
We evaluated the use of the peptide mass fingerprint (PMF) obtained by matrix assisted laser desorption and ionization (MALDI) time-of-flight mass spectrometry (TOF-MS) to track changes in the structure of a protein. The first problem we had to overcome was the inherent complexity of the PMF, which makes it difficult to compare. We dealt with this problem by developing a cluster-based comparison algorithm which takes into account the proportional error made by the mass spectrometer. This procedure involves grouping together similar masses in an intelligent manner, so that we can determine which data correspond to the same peptide (any slight differences can be explained as experimental errors), and which of them are too different and thus more likely to represent different peptides. The proposed algorithm was applied to track changes in a commercially available monoclonal antibody (mAb), namely rituximab (RTX), prepared under the usual hospital conditions and stored refrigerated (4 °C) and frozen (−20 °C) for a long term study. PMFs were obtained periodically over three months. For each checked time, five replicates of the PMFs were obtained in order to evaluate the similarities between them by means of the occurrences of the particular peptides (m/z). After applying the algorithm to the PMF, different approaches were used to analyse the results. Surprisingly, all of them suggested that there were no differences between the two storage conditions tested, i.e. the RTX samples were almost equally well preserved when stored refrigerated at 4 °C or frozen at −20 °C. The cluster-based methodology is new in protein mass spectrometry and could be useful as an easy test for major changes in proteins and biopharmaceutics for diverse applications in industry and other fields, and could provide additional stability data in relation to the practical use of anticancer drugs.
- 18 April 2006
- Published by Wiley in Proteomics
- Vol. 6 (S1) , S282-S292
Proteomic analysis of plasma from patients with systemic lupus erythematosus: Increased presence of haptoglobin α2 polypeptide chains over the α1 isoforms
In the present study plasma samples from 15 systemic lupus erythematosus (SLE) patients and 16 healthy controls of initially unknown haptoglobin (Hp) phenotype were separated by 2‐DE, and tryptic digests of the excised Hpα polypeptide chain spots were analyzed by MALDI‐TOF‐MS. Selected tryptic peptides were sequenced by nano‐(n)ESI‐IT MS/MS. The six major Hp phenotypes were present, although with distinct frequencies in controls and SLE patients. Thus, there were an increased proportion of SLE patients with Hp 2–2, or Hp 2–1S phenotypes. The Hp phenotype distribution resulted in allele frequencies of 0 625 (Hp2), 0.281 (Hp1S), and 0.093 (Hp1F) in healthy controls, correlating fairly well with the allele frequencies of European populations. In contrast, the Hp allele frequencies of the SLE patients were 0.733 (Hp2), 0.233 (Hp1S), and 0.033 (Hp11F), which clearly indicated an increased frequency of Hp2, a similar proportion of Hp1S and a diminished proportion of Hp1F in SLE patients compared with that in healthy controls. Preferential Hpα2 expression in SLE patients may contribute to some of the clinical manifestations of the disease such as hypergammaglobulinemia, systemic vasculitis, and cardiovascular disorders.
- 18 April 2006
- Published by Wiley in Proteomics
- Vol. 6 (S1) , S282-S292
Proteomic analysis of plasma from patients with systemic lupus erythematosus: Increased presence of haptoglobin α2 polypeptide chains over the α1 isoforms
In the present study plasma samples from 15 systemic lupus erythematosus (SLE) patients and 16 healthy controls of initially unknown haptoglobin (Hp) phenotype were separated by 2‐DE, and tryptic digests of the excised Hpα polypeptide chain spots were analyzed by MALDI‐TOF‐MS. Selected tryptic peptides were sequenced by nano‐(n)ESI‐IT MS/MS. The six major Hp phenotypes were present, although with distinct frequencies in controls and SLE patients. Thus, there were an increased proportion of SLE patients with Hp 2–2, or Hp 2–1S phenotypes. The Hp phenotype distribution resulted in allele frequencies of 0 625 (Hp2), 0.281 (Hp1S), and 0.093 (Hp1F) in healthy controls, correlating fairly well with the allele frequencies of European populations. In contrast, the Hp allele frequencies of the SLE patients were 0.733 (Hp2), 0.233 (Hp1S), and 0.033 (Hp11F), which clearly indicated an increased frequency of Hp2, a similar proportion of Hp1S and a diminished proportion of Hp1F in SLE patients compared with that in healthy controls. Preferential Hpα2 expression in SLE patients may contribute to some of the clinical manifestations of the disease such as hypergammaglobulinemia, systemic vasculitis, and cardiovascular disorders.